Airway diseases
Pulmonary vascular diseases
Oral presentation
Tobacco and nicotine research during the pandemic
COVID
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Methods :
Physiology, General respiratory patient care, Cell and molecular biology, Epidemiology, Public health
14:45
Introduction
1
OA2575
14:50
Electronic cigarettes containing nicotine increase thrombotic activity and impair microcirculation.
G. Lyytinen(Höganäs, Sweden)
COI
2
14:55
Preconceptional e-cigarette use alters tracheal gene expression in F1 Drosophila melanogaster larvae
H. Angstmann(Borstel, Germany)
COI
3
15:00
Comparison of gaseous emissions of conventional and heated tobacco products
E. Zervas(Patra, Greece)
COI
4
15:05
Increased exposure to tobacco smoke for children during the COVID-19 era
C. Bossley(London, United Kingdom)
COI
5
15:10
Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia
M. Xie(410008, China)
COI
6
15:15
Inpatient smoking cessation during COVID-19: a highly teachable moment
G. Jones(Liverpool, United Kingdom)
COI
7
15:20
The presence of smoking in popular movies available in online streaming platform. A relentless fire still burning.
D. Lykouras(Patra, Greece)
COI
8
15:25
Most users quit e-cigarettes without succeeding to quit smoking
L. Hedman(Luleå, Sweden)
COI
9
15:30
Survey on the compliance with plain packaging regulation
E. Dagli(Istanbul, Turkey)
COI
10
15:35
Late Breaking Abstract - Brief use of heated tobacco products causes increased arterial stiffness and thrombotic activity
G. Lyytinen(Höganäs, Sweden)
COI
11
15:40
Discussion
12
OA2586
. . .
